nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—Propafenone—Propranolol—migraine	0.314	1	CrCrCtD
Mirabegron—ADRB3—Timolol—migraine	0.139	0.247	CbGbCtD
Mirabegron—ADRB3—Propranolol—migraine	0.124	0.22	CbGbCtD
Mirabegron—ORM1—Propranolol—migraine	0.0612	0.109	CbGbCtD
Mirabegron—ORM1—Amitriptyline—migraine	0.0529	0.0942	CbGbCtD
Mirabegron—SLCO1A2—Verapamil—migraine	0.0342	0.0609	CbGbCtD
Mirabegron—ALB—Amitriptyline—migraine	0.0223	0.0396	CbGbCtD
Mirabegron—ABCB1—Timolol—migraine	0.0151	0.0269	CbGbCtD
Mirabegron—CYP2D6—Timolol—migraine	0.0142	0.0253	CbGbCtD
Mirabegron—ABCB1—Propranolol—migraine	0.0135	0.024	CbGbCtD
Mirabegron—CYP2D6—Propranolol—migraine	0.0127	0.0226	CbGbCtD
Mirabegron—ABCB1—Amitriptyline—migraine	0.0116	0.0207	CbGbCtD
Mirabegron—CYP2D6—Amitriptyline—migraine	0.011	0.0195	CbGbCtD
Mirabegron—ABCB1—Verapamil—migraine	0.00924	0.0164	CbGbCtD
Mirabegron—CYP2D6—Verapamil—migraine	0.00871	0.0155	CbGbCtD
Mirabegron—CYP3A4—Propranolol—migraine	0.00807	0.0144	CbGbCtD
Mirabegron—CYP3A4—Amitriptyline—migraine	0.00698	0.0124	CbGbCtD
Mirabegron—CYP3A4—Valproic Acid—migraine	0.00636	0.0113	CbGbCtD
Mirabegron—CYP3A4—Topiramate—migraine	0.00574	0.0102	CbGbCtD
Mirabegron—CYP3A4—Verapamil—migraine	0.00554	0.00985	CbGbCtD
Mirabegron—ADRB3—Monoamine GPCRs—HTR1D—migraine	0.00119	0.0553	CbGpPWpGaD
Mirabegron—ADRB3—Monoamine GPCRs—HTR2B—migraine	0.00111	0.0514	CbGpPWpGaD
Mirabegron—ADRB3—Amine ligand-binding receptors—HTR1D—migraine	0.001	0.0465	CbGpPWpGaD
Mirabegron—ADRB3—Amine ligand-binding receptors—HTR2B—migraine	0.000931	0.0432	CbGpPWpGaD
Mirabegron—ALB—Scavenging of heme from plasma—LRP1—migraine	0.000724	0.0336	CbGpPWpGaD
Mirabegron—ADRB3—Monoamine GPCRs—HTR1B—migraine	0.000722	0.0335	CbGpPWpGaD
Mirabegron—ADRB3—Monoamine GPCRs—HTR1A—migraine	0.000695	0.0323	CbGpPWpGaD
Mirabegron—ADRB3—Monoamine GPCRs—HTR2C—migraine	0.000671	0.0312	CbGpPWpGaD
Mirabegron—Blood pressure increased—Timolol—migraine	0.00063	0.00613	CcSEcCtD
Mirabegron—Influenza—Verapamil—migraine	0.000626	0.0061	CcSEcCtD
Mirabegron—Nephrolithiasis—Topiramate—migraine	0.000614	0.00598	CcSEcCtD
Mirabegron—Infestation—Propranolol—migraine	0.000607	0.00591	CcSEcCtD
Mirabegron—Infestation NOS—Propranolol—migraine	0.000607	0.00591	CcSEcCtD
Mirabegron—ADRB3—Amine ligand-binding receptors—HTR1B—migraine	0.000607	0.0282	CbGpPWpGaD
Mirabegron—Stevens-Johnson syndrome—Propranolol—migraine	0.000602	0.00586	CcSEcCtD
Mirabegron—Gamma-glutamyltransferase increased—Topiramate—migraine	0.0006	0.00584	CcSEcCtD
Mirabegron—ADRB3—Monoamine GPCRs—HTR7—migraine	0.000588	0.0273	CbGpPWpGaD
Mirabegron—Blood pressure increased—Gabapentin—migraine	0.000587	0.00571	CcSEcCtD
Mirabegron—ADRB3—Amine ligand-binding receptors—HTR1A—migraine	0.000584	0.0271	CbGpPWpGaD
Mirabegron—Upper respiratory tract infection—Verapamil—migraine	0.000582	0.00567	CcSEcCtD
Mirabegron—Dry eye—Timolol—migraine	0.000582	0.00567	CcSEcCtD
Mirabegron—Cystitis noninfective—Gabapentin—migraine	0.000573	0.00558	CcSEcCtD
Mirabegron—ADRB3—G alpha (s) signalling events—CALCRL—migraine	0.000569	0.0264	CbGpPWpGaD
Mirabegron—ADRB3—G alpha (s) signalling events—RAMP1—migraine	0.000569	0.0264	CbGpPWpGaD
Mirabegron—Cystitis—Gabapentin—migraine	0.000567	0.00552	CcSEcCtD
Mirabegron—ADRB3—Amine ligand-binding receptors—HTR2C—migraine	0.000564	0.0262	CbGpPWpGaD
Mirabegron—Stevens-Johnson syndrome—Verapamil—migraine	0.000554	0.00539	CcSEcCtD
Mirabegron—Vision blurred—Amitriptyline—migraine	0.000549	0.00535	CcSEcCtD
Mirabegron—Dry eye—Gabapentin—migraine	0.000542	0.00528	CcSEcCtD
Mirabegron—Bladder pain—Gabapentin—migraine	0.000531	0.00516	CcSEcCtD
Mirabegron—Sinusitis—Verapamil—migraine	0.000524	0.0051	CcSEcCtD
Mirabegron—Erythema multiforme—Propranolol—migraine	0.000515	0.00502	CcSEcCtD
Mirabegron—Palpitations—Amitriptyline—migraine	0.000515	0.00501	CcSEcCtD
Mirabegron—Osteoarthritis—Valproic Acid—migraine	0.000514	0.005	CcSEcCtD
Mirabegron—Cardiac disorder—Propranolol—migraine	0.000506	0.00492	CcSEcCtD
Mirabegron—Hypertension—Amitriptyline—migraine	0.000503	0.0049	CcSEcCtD
Mirabegron—Rhinitis—Verapamil—migraine	0.000503	0.00489	CcSEcCtD
Mirabegron—ADRB3—Amine ligand-binding receptors—HTR7—migraine	0.000494	0.0229	CbGpPWpGaD
Mirabegron—Dry mouth—Amitriptyline—migraine	0.000485	0.00472	CcSEcCtD
Mirabegron—Cystitis noninfective—Topiramate—migraine	0.000482	0.00469	CcSEcCtD
Mirabegron—Cystitis—Topiramate—migraine	0.000477	0.00464	CcSEcCtD
Mirabegron—Vascular purpura—Gabapentin—migraine	0.000476	0.00464	CcSEcCtD
Mirabegron—Erythema multiforme—Verapamil—migraine	0.000474	0.00461	CcSEcCtD
Mirabegron—Cerebrovascular accident—Timolol—migraine	0.000467	0.00454	CcSEcCtD
Mirabegron—Vaginal infection—Topiramate—migraine	0.000466	0.00454	CcSEcCtD
Mirabegron—Breast disorder—Valproic Acid—migraine	0.000464	0.00452	CcSEcCtD
Mirabegron—Tachycardia—Amitriptyline—migraine	0.000464	0.00452	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Valproic Acid—migraine	0.000463	0.0045	CcSEcCtD
Mirabegron—Osteoarthritis—Timolol—migraine	0.000457	0.00445	CcSEcCtD
Mirabegron—Dry eye—Topiramate—migraine	0.000456	0.00444	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Valproic Acid—migraine	0.000453	0.00441	CcSEcCtD
Mirabegron—Atrial fibrillation—Gabapentin—migraine	0.000449	0.00438	CcSEcCtD
Mirabegron—Bladder pain—Topiramate—migraine	0.000446	0.00435	CcSEcCtD
Mirabegron—Neoplasm—Topiramate—migraine	0.000446	0.00435	CcSEcCtD
Mirabegron—Influenza—Valproic Acid—migraine	0.000444	0.00432	CcSEcCtD
Mirabegron—Purpura—Gabapentin—migraine	0.000442	0.0043	CcSEcCtD
Mirabegron—Cerebrovascular accident—Gabapentin—migraine	0.000435	0.00423	CcSEcCtD
Mirabegron—Osteoarthritis—Gabapentin—migraine	0.000426	0.00415	CcSEcCtD
Mirabegron—Dyspepsia—Amitriptyline—migraine	0.000419	0.00408	CcSEcCtD
Mirabegron—Breast disorder—Timolol—migraine	0.000413	0.00402	CcSEcCtD
Mirabegron—ADRB3—Monoamine GPCRs—HTR2A—migraine	0.000412	0.0191	CbGpPWpGaD
Mirabegron—Vision blurred—Verapamil—migraine	0.000411	0.004	CcSEcCtD
Mirabegron—Fatigue—Amitriptyline—migraine	0.00041	0.00399	CcSEcCtD
Mirabegron—Nasopharyngitis—Timolol—migraine	0.000409	0.00398	CcSEcCtD
Mirabegron—Constipation—Amitriptyline—migraine	0.000407	0.00396	CcSEcCtD
Mirabegron—Urinary retention—Gabapentin—migraine	0.000405	0.00394	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000401	0.00391	CcSEcCtD
Mirabegron—Vascular purpura—Topiramate—migraine	0.000401	0.0039	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Valproic Acid—migraine	0.000393	0.00382	CcSEcCtD
Mirabegron—Palpitations—Verapamil—migraine	0.000386	0.00375	CcSEcCtD
Mirabegron—Breast disorder—Gabapentin—migraine	0.000385	0.00375	CcSEcCtD
Mirabegron—Urinary tract infection—Valproic Acid—migraine	0.000385	0.00375	CcSEcCtD
Mirabegron—Infection—Propranolol—migraine	0.000385	0.00374	CcSEcCtD
Mirabegron—Nasopharyngitis—Gabapentin—migraine	0.000381	0.00371	CcSEcCtD
Mirabegron—Urticaria—Amitriptyline—migraine	0.000378	0.00368	CcSEcCtD
Mirabegron—Gastritis—Gabapentin—migraine	0.000377	0.00367	CcSEcCtD
Mirabegron—Hypertension—Verapamil—migraine	0.000377	0.00367	CcSEcCtD
Mirabegron—Skin disorder—Propranolol—migraine	0.000376	0.00366	CcSEcCtD
Mirabegron—ADRB3—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000372	0.0173	CbGpPWpGaD
Mirabegron—Purpura—Topiramate—migraine	0.000372	0.00362	CcSEcCtD
Mirabegron—Arthralgia—Verapamil—migraine	0.000372	0.00362	CcSEcCtD
Mirabegron—Sinusitis—Valproic Acid—migraine	0.000371	0.00362	CcSEcCtD
Mirabegron—Influenza—Gabapentin—migraine	0.000368	0.00358	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Timolol—migraine	0.000367	0.00358	CcSEcCtD
Mirabegron—Dry mouth—Verapamil—migraine	0.000363	0.00354	CcSEcCtD
Mirabegron—Osteoarthritis—Topiramate—migraine	0.000358	0.00349	CcSEcCtD
Mirabegron—Rhinitis—Valproic Acid—migraine	0.000356	0.00347	CcSEcCtD
Mirabegron—Infection—Verapamil—migraine	0.000354	0.00344	CcSEcCtD
Mirabegron—Urinary tract disorder—Valproic Acid—migraine	0.000351	0.00342	CcSEcCtD
Mirabegron—Connective tissue disorder—Valproic Acid—migraine	0.000349	0.0034	CcSEcCtD
Mirabegron—Urethral disorder—Valproic Acid—migraine	0.000348	0.00339	CcSEcCtD
Mirabegron—Tachycardia—Verapamil—migraine	0.000348	0.00338	CcSEcCtD
Mirabegron—ADRB3—Amine ligand-binding receptors—HTR2A—migraine	0.000346	0.0161	CbGpPWpGaD
Mirabegron—Upper respiratory tract infection—Gabapentin—migraine	0.000342	0.00333	CcSEcCtD
Mirabegron—Asthenia—Amitriptyline—migraine	0.000341	0.00332	CcSEcCtD
Mirabegron—Dyspepsia—Propranolol—migraine	0.000341	0.00332	CcSEcCtD
Mirabegron—Urinary retention—Topiramate—migraine	0.000341	0.00332	CcSEcCtD
Mirabegron—Pruritus—Amitriptyline—migraine	0.000336	0.00328	CcSEcCtD
Mirabegron—Erythema multiforme—Valproic Acid—migraine	0.000336	0.00327	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Propranolol—migraine	0.000334	0.00325	CcSEcCtD
Mirabegron—Fatigue—Propranolol—migraine	0.000334	0.00325	CcSEcCtD
Mirabegron—Eye disorder—Valproic Acid—migraine	0.000332	0.00323	CcSEcCtD
Mirabegron—Constipation—Propranolol—migraine	0.000331	0.00322	CcSEcCtD
Mirabegron—Sinusitis—Timolol—migraine	0.000331	0.00322	CcSEcCtD
Mirabegron—Infestation—Gabapentin—migraine	0.000328	0.0032	CcSEcCtD
Mirabegron—Infestation NOS—Gabapentin—migraine	0.000328	0.0032	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Gabapentin—migraine	0.000325	0.00317	CcSEcCtD
Mirabegron—Diarrhoea—Amitriptyline—migraine	0.000325	0.00317	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Verapamil—migraine	0.000325	0.00316	CcSEcCtD
Mirabegron—Breast disorder—Topiramate—migraine	0.000324	0.00315	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Topiramate—migraine	0.000323	0.00314	CcSEcCtD
Mirabegron—Nasopharyngitis—Topiramate—migraine	0.00032	0.00312	CcSEcCtD
Mirabegron—Urinary tract infection—Gabapentin—migraine	0.000319	0.00311	CcSEcCtD
Mirabegron—Rhinitis—Timolol—migraine	0.000317	0.00309	CcSEcCtD
Mirabegron—Gastritis—Topiramate—migraine	0.000317	0.00309	CcSEcCtD
Mirabegron—Gastrointestinal pain—Propranolol—migraine	0.000317	0.00308	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Topiramate—migraine	0.000316	0.00308	CcSEcCtD
Mirabegron—Dizziness—Amitriptyline—migraine	0.000314	0.00306	CcSEcCtD
Mirabegron—Dyspepsia—Verapamil—migraine	0.000314	0.00305	CcSEcCtD
Mirabegron—Abdominal distension—Topiramate—migraine	0.000312	0.00304	CcSEcCtD
Mirabegron—Connective tissue disorder—Timolol—migraine	0.000311	0.00303	CcSEcCtD
Mirabegron—Sinusitis—Gabapentin—migraine	0.000308	0.003	CcSEcCtD
Mirabegron—Urticaria—Propranolol—migraine	0.000308	0.00299	CcSEcCtD
Mirabegron—Fatigue—Verapamil—migraine	0.000307	0.00299	CcSEcCtD
Mirabegron—Abdominal pain—Propranolol—migraine	0.000306	0.00298	CcSEcCtD
Mirabegron—Constipation—Verapamil—migraine	0.000305	0.00297	CcSEcCtD
Mirabegron—Rash—Amitriptyline—migraine	0.0003	0.00292	CcSEcCtD
Mirabegron—Dermatitis—Amitriptyline—migraine	0.0003	0.00292	CcSEcCtD
Mirabegron—Back pain—Valproic Acid—migraine	0.000299	0.00291	CcSEcCtD
Mirabegron—Headache—Amitriptyline—migraine	0.000298	0.0029	CcSEcCtD
Mirabegron—Eye disorder—Timolol—migraine	0.000296	0.00288	CcSEcCtD
Mirabegron—Rhinitis—Gabapentin—migraine	0.000295	0.00288	CcSEcCtD
Mirabegron—Cardiac disorder—Timolol—migraine	0.000294	0.00286	CcSEcCtD
Mirabegron—BCHE—Neuronal System—KCNK18—migraine	0.000292	0.0135	CbGpPWpGaD
Mirabegron—Vision blurred—Valproic Acid—migraine	0.000292	0.00284	CcSEcCtD
Mirabegron—Urinary tract disorder—Gabapentin—migraine	0.000291	0.00283	CcSEcCtD
Mirabegron—Connective tissue disorder—Gabapentin—migraine	0.00029	0.00282	CcSEcCtD
Mirabegron—Urethral disorder—Gabapentin—migraine	0.000289	0.00281	CcSEcCtD
Mirabegron—ALB—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—migraine	0.000289	0.0134	CbGpPWpGaD
Mirabegron—Upper respiratory tract infection—Topiramate—migraine	0.000288	0.0028	CcSEcCtD
Mirabegron—Urticaria—Verapamil—migraine	0.000283	0.00275	CcSEcCtD
Mirabegron—Nausea—Amitriptyline—migraine	0.000282	0.00275	CcSEcCtD
Mirabegron—Erythema multiforme—Gabapentin—migraine	0.000279	0.00271	CcSEcCtD
Mirabegron—Asthenia—Propranolol—migraine	0.000278	0.0027	CcSEcCtD
Mirabegron—Infestation—Topiramate—migraine	0.000276	0.00269	CcSEcCtD
Mirabegron—Infestation NOS—Topiramate—migraine	0.000276	0.00269	CcSEcCtD
Mirabegron—Eye disorder—Gabapentin—migraine	0.000275	0.00268	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Topiramate—migraine	0.000274	0.00267	CcSEcCtD
Mirabegron—Cardiac disorder—Gabapentin—migraine	0.000273	0.00266	CcSEcCtD
Mirabegron—Palpitations—Valproic Acid—migraine	0.000273	0.00266	CcSEcCtD
Mirabegron—Urinary tract infection—Topiramate—migraine	0.000268	0.00261	CcSEcCtD
Mirabegron—Hypertension—Valproic Acid—migraine	0.000267	0.0026	CcSEcCtD
Mirabegron—Diarrhoea—Propranolol—migraine	0.000265	0.00258	CcSEcCtD
Mirabegron—Arthralgia—Valproic Acid—migraine	0.000263	0.00256	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000262	0.00255	CcSEcCtD
Mirabegron—Vision blurred—Timolol—migraine	0.00026	0.00253	CcSEcCtD
Mirabegron—Sinusitis—Topiramate—migraine	0.000259	0.00252	CcSEcCtD
Mirabegron—Dry mouth—Valproic Acid—migraine	0.000258	0.00251	CcSEcCtD
Mirabegron—Dizziness—Propranolol—migraine	0.000256	0.00249	CcSEcCtD
Mirabegron—Asthenia—Verapamil—migraine	0.000256	0.00249	CcSEcCtD
Mirabegron—Pruritus—Verapamil—migraine	0.000252	0.00245	CcSEcCtD
Mirabegron—Infection—Valproic Acid—migraine	0.000251	0.00244	CcSEcCtD
Mirabegron—Rhinitis—Topiramate—migraine	0.000249	0.00242	CcSEcCtD
Mirabegron—Back pain—Gabapentin—migraine	0.000248	0.00242	CcSEcCtD
Mirabegron—Tachycardia—Valproic Acid—migraine	0.000246	0.0024	CcSEcCtD
Mirabegron—Skin disorder—Valproic Acid—migraine	0.000245	0.00239	CcSEcCtD
Mirabegron—Urinary tract disorder—Topiramate—migraine	0.000245	0.00238	CcSEcCtD
Mirabegron—Rash—Propranolol—migraine	0.000244	0.00238	CcSEcCtD
Mirabegron—Dermatitis—Propranolol—migraine	0.000244	0.00237	CcSEcCtD
Mirabegron—Diarrhoea—Verapamil—migraine	0.000244	0.00237	CcSEcCtD
Mirabegron—Connective tissue disorder—Topiramate—migraine	0.000244	0.00237	CcSEcCtD
Mirabegron—Palpitations—Timolol—migraine	0.000243	0.00237	CcSEcCtD
Mirabegron—Urethral disorder—Topiramate—migraine	0.000243	0.00237	CcSEcCtD
Mirabegron—Vision blurred—Gabapentin—migraine	0.000242	0.00235	CcSEcCtD
Mirabegron—Hypertension—Timolol—migraine	0.000238	0.00232	CcSEcCtD
Mirabegron—ADRB3—G alpha (s) signalling events—NPS—migraine	0.000237	0.011	CbGpPWpGaD
Mirabegron—Dizziness—Verapamil—migraine	0.000236	0.00229	CcSEcCtD
Mirabegron—Arthralgia—Timolol—migraine	0.000235	0.00228	CcSEcCtD
Mirabegron—Erythema multiforme—Topiramate—migraine	0.000234	0.00228	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000233	0.00227	CcSEcCtD
Mirabegron—Eye disorder—Topiramate—migraine	0.000232	0.00226	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Valproic Acid—migraine	0.00023	0.00224	CcSEcCtD
Mirabegron—Cardiac disorder—Topiramate—migraine	0.00023	0.00224	CcSEcCtD
Mirabegron—Nausea—Propranolol—migraine	0.00023	0.00224	CcSEcCtD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00023	0.0107	CbGpPWpGaD
Mirabegron—Dry mouth—Timolol—migraine	0.000229	0.00223	CcSEcCtD
Mirabegron—Palpitations—Gabapentin—migraine	0.000227	0.00221	CcSEcCtD
Mirabegron—Rash—Verapamil—migraine	0.000225	0.00219	CcSEcCtD
Mirabegron—Dermatitis—Verapamil—migraine	0.000224	0.00218	CcSEcCtD
Mirabegron—Infection—Timolol—migraine	0.000223	0.00217	CcSEcCtD
Mirabegron—Headache—Verapamil—migraine	0.000223	0.00217	CcSEcCtD
Mirabegron—Dyspepsia—Valproic Acid—migraine	0.000222	0.00216	CcSEcCtD
Mirabegron—Hypertension—Gabapentin—migraine	0.000221	0.00216	CcSEcCtD
Mirabegron—Arthralgia—Gabapentin—migraine	0.000218	0.00213	CcSEcCtD
Mirabegron—Skin disorder—Timolol—migraine	0.000218	0.00213	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Valproic Acid—migraine	0.000218	0.00212	CcSEcCtD
Mirabegron—ADRB3—G alpha (s) signalling events—CALCA—migraine	0.000218	0.0101	CbGpPWpGaD
Mirabegron—Fatigue—Valproic Acid—migraine	0.000218	0.00212	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000217	0.00211	CcSEcCtD
Mirabegron—Constipation—Valproic Acid—migraine	0.000216	0.0021	CcSEcCtD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000214	0.00992	CbGpPWpGaD
Mirabegron—Dry mouth—Gabapentin—migraine	0.000214	0.00208	CcSEcCtD
Mirabegron—Nausea—Verapamil—migraine	0.000212	0.00206	CcSEcCtD
Mirabegron—Back pain—Topiramate—migraine	0.000209	0.00203	CcSEcCtD
Mirabegron—Infection—Gabapentin—migraine	0.000208	0.00202	CcSEcCtD
Mirabegron—Gastrointestinal pain—Valproic Acid—migraine	0.000207	0.00201	CcSEcCtD
Mirabegron—ADRB3—GPCR ligand binding—CALCRL—migraine	0.000206	0.00958	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—RAMP1—migraine	0.000206	0.00958	CbGpPWpGaD
Mirabegron—Musculoskeletal discomfort—Timolol—migraine	0.000205	0.00199	CcSEcCtD
Mirabegron—Tachycardia—Gabapentin—migraine	0.000204	0.00199	CcSEcCtD
Mirabegron—ADRB3—G alpha (s) signalling events—HTR7—migraine	0.000204	0.00946	CbGpPWpGaD
Mirabegron—Vision blurred—Topiramate—migraine	0.000203	0.00198	CcSEcCtD
Mirabegron—Skin disorder—Gabapentin—migraine	0.000203	0.00198	CcSEcCtD
Mirabegron—Urticaria—Valproic Acid—migraine	0.000201	0.00195	CcSEcCtD
Mirabegron—Abdominal pain—Valproic Acid—migraine	0.0002	0.00194	CcSEcCtD
Mirabegron—Dyspepsia—Timolol—migraine	0.000198	0.00193	CcSEcCtD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000197	0.00914	CbGpPWpGaD
Mirabegron—Gastrointestinal disorder—Timolol—migraine	0.000194	0.00189	CcSEcCtD
Mirabegron—Fatigue—Timolol—migraine	0.000194	0.00189	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Gabapentin—migraine	0.000191	0.00186	CcSEcCtD
Mirabegron—Palpitations—Topiramate—migraine	0.000191	0.00186	CcSEcCtD
Mirabegron—Hypertension—Topiramate—migraine	0.000186	0.00181	CcSEcCtD
Mirabegron—BCHE—Transmission across Chemical Synapses—CACNA1A—migraine	0.000186	0.00863	CbGpPWpGaD
Mirabegron—Dyspepsia—Gabapentin—migraine	0.000184	0.00179	CcSEcCtD
Mirabegron—Gastrointestinal pain—Timolol—migraine	0.000184	0.00179	CcSEcCtD
Mirabegron—Arthralgia—Topiramate—migraine	0.000184	0.00179	CcSEcCtD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000183	0.0085	CbGpPWpGaD
Mirabegron—BCHE—Peptide hormone metabolism—ACE—migraine	0.000183	0.00848	CbGpPWpGaD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000182	0.00178	CcSEcCtD
Mirabegron—Asthenia—Valproic Acid—migraine	0.000181	0.00176	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Gabapentin—migraine	0.000181	0.00176	CcSEcCtD
Mirabegron—Fatigue—Gabapentin—migraine	0.00018	0.00176	CcSEcCtD
Mirabegron—Dry mouth—Topiramate—migraine	0.00018	0.00175	CcSEcCtD
Mirabegron—Constipation—Gabapentin—migraine	0.000179	0.00174	CcSEcCtD
Mirabegron—Pruritus—Valproic Acid—migraine	0.000179	0.00174	CcSEcCtD
Mirabegron—Urticaria—Timolol—migraine	0.000179	0.00174	CcSEcCtD
Mirabegron—Abdominal pain—Timolol—migraine	0.000178	0.00173	CcSEcCtD
Mirabegron—Infection—Topiramate—migraine	0.000175	0.0017	CcSEcCtD
Mirabegron—Diarrhoea—Valproic Acid—migraine	0.000173	0.00168	CcSEcCtD
Mirabegron—Tachycardia—Topiramate—migraine	0.000172	0.00167	CcSEcCtD
Mirabegron—Gastrointestinal pain—Gabapentin—migraine	0.000171	0.00167	CcSEcCtD
Mirabegron—Skin disorder—Topiramate—migraine	0.000171	0.00167	CcSEcCtD
Mirabegron—Dizziness—Valproic Acid—migraine	0.000167	0.00163	CcSEcCtD
Mirabegron—Urticaria—Gabapentin—migraine	0.000166	0.00162	CcSEcCtD
Mirabegron—Abdominal pain—Gabapentin—migraine	0.000165	0.00161	CcSEcCtD
Mirabegron—Asthenia—Timolol—migraine	0.000161	0.00157	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Topiramate—migraine	0.00016	0.00156	CcSEcCtD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—TRPM8—migraine	0.000159	0.0074	CbGpPWpGaD
Mirabegron—Rash—Valproic Acid—migraine	0.000159	0.00155	CcSEcCtD
Mirabegron—Dermatitis—Valproic Acid—migraine	0.000159	0.00155	CcSEcCtD
Mirabegron—Pruritus—Timolol—migraine	0.000159	0.00155	CcSEcCtD
Mirabegron—Headache—Valproic Acid—migraine	0.000158	0.00154	CcSEcCtD
Mirabegron—Dyspepsia—Topiramate—migraine	0.000155	0.00151	CcSEcCtD
Mirabegron—Diarrhoea—Timolol—migraine	0.000154	0.0015	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Topiramate—migraine	0.000152	0.00148	CcSEcCtD
Mirabegron—Fatigue—Topiramate—migraine	0.000152	0.00148	CcSEcCtD
Mirabegron—Constipation—Topiramate—migraine	0.000151	0.00147	CcSEcCtD
Mirabegron—Asthenia—Gabapentin—migraine	0.00015	0.00146	CcSEcCtD
Mirabegron—ADRB3—GPCR ligand binding—HTR1D—migraine	0.00015	0.00696	CbGpPWpGaD
Mirabegron—Nausea—Valproic Acid—migraine	0.00015	0.00146	CcSEcCtD
Mirabegron—Dizziness—Timolol—migraine	0.000149	0.00145	CcSEcCtD
Mirabegron—Pruritus—Gabapentin—migraine	0.000148	0.00144	CcSEcCtD
Mirabegron—Gastrointestinal pain—Topiramate—migraine	0.000144	0.0014	CcSEcCtD
Mirabegron—Diarrhoea—Gabapentin—migraine	0.000143	0.00139	CcSEcCtD
Mirabegron—BCHE—Neuronal System—CACNA1A—migraine	0.000142	0.00661	CbGpPWpGaD
Mirabegron—Rash—Timolol—migraine	0.000142	0.00138	CcSEcCtD
Mirabegron—Dermatitis—Timolol—migraine	0.000142	0.00138	CcSEcCtD
Mirabegron—Headache—Timolol—migraine	0.000141	0.00137	CcSEcCtD
Mirabegron—Urticaria—Topiramate—migraine	0.00014	0.00136	CcSEcCtD
Mirabegron—ADRB3—GPCR ligand binding—HTR2B—migraine	0.000139	0.00647	CbGpPWpGaD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000139	0.00647	CbGpPWpGaD
Mirabegron—Abdominal pain—Topiramate—migraine	0.000139	0.00136	CcSEcCtD
Mirabegron—Dizziness—Gabapentin—migraine	0.000138	0.00135	CcSEcCtD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000134	0.00622	CbGpPWpGaD
Mirabegron—Nausea—Timolol—migraine	0.000134	0.0013	CcSEcCtD
Mirabegron—Rash—Gabapentin—migraine	0.000132	0.00129	CcSEcCtD
Mirabegron—Dermatitis—Gabapentin—migraine	0.000132	0.00128	CcSEcCtD
Mirabegron—Headache—Gabapentin—migraine	0.000131	0.00128	CcSEcCtD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00013	0.00601	CbGpPWpGaD
Mirabegron—Asthenia—Topiramate—migraine	0.000126	0.00123	CcSEcCtD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000126	0.00585	CbGpPWpGaD
Mirabegron—Pruritus—Topiramate—migraine	0.000125	0.00121	CcSEcCtD
Mirabegron—Nausea—Gabapentin—migraine	0.000124	0.00121	CcSEcCtD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000121	0.00561	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000121	0.00561	CbGpPWpGaD
Mirabegron—Diarrhoea—Topiramate—migraine	0.000121	0.00117	CcSEcCtD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000119	0.00554	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—RAMP1—migraine	0.000117	0.00542	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—CALCRL—migraine	0.000117	0.00542	CbGpPWpGaD
Mirabegron—Dizziness—Topiramate—migraine	0.000116	0.00113	CcSEcCtD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000115	0.00533	CbGpPWpGaD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000113	0.00527	CbGpPWpGaD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000113	0.00525	CbGpPWpGaD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000113	0.00525	CbGpPWpGaD
Mirabegron—Rash—Topiramate—migraine	0.000111	0.00108	CcSEcCtD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000111	0.00515	CbGpPWpGaD
Mirabegron—Dermatitis—Topiramate—migraine	0.000111	0.00108	CcSEcCtD
Mirabegron—Headache—Topiramate—migraine	0.00011	0.00107	CcSEcCtD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000108	0.00501	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—RAMP1—migraine	0.000106	0.00492	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CALCRL—migraine	0.000106	0.00492	CbGpPWpGaD
Mirabegron—Nausea—Topiramate—migraine	0.000105	0.00102	CcSEcCtD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—HTR3A—migraine	0.000103	0.00477	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—MTHFR—migraine	0.000102	0.00474	CbGpPWpGaD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	9.72e-05	0.00451	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—HTR1B—migraine	9.09e-05	0.00422	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—HTR1A—migraine	8.75e-05	0.00406	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—NPS—migraine	8.62e-05	0.004	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—TAC1—migraine	8.62e-05	0.004	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—HTR1D—migraine	8.48e-05	0.00394	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—HTR2C—migraine	8.45e-05	0.00392	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—MTHFR—migraine	8.32e-05	0.00386	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—EDNRA—migraine	8.22e-05	0.00382	CbGpPWpGaD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	7.95e-05	0.00369	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—CALCA—migraine	7.91e-05	0.00367	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—HTR2B—migraine	7.88e-05	0.00366	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—TRPM8—migraine	7.79e-05	0.00361	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HTR1D—migraine	7.7e-05	0.00357	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—HTR7—migraine	7.4e-05	0.00344	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HTR2B—migraine	7.16e-05	0.00332	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	6.82e-05	0.00317	CbGpPWpGaD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	6.81e-05	0.00316	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—MTHFR—migraine	6.61e-05	0.00307	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CALCRL—migraine	6.26e-05	0.00291	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RAMP1—migraine	6.26e-05	0.00291	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	5.9e-05	0.00274	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	5.9e-05	0.00274	CbGpPWpGaD
Mirabegron—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	5.84e-05	0.00271	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—HTR2A—migraine	5.18e-05	0.00241	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	5.17e-05	0.0024	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	5.17e-05	0.0024	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—HTR1B—migraine	5.14e-05	0.00238	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—HTR3A—migraine	5.02e-05	0.00233	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—HTR1A—migraine	4.94e-05	0.00229	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—TAC1—migraine	4.87e-05	0.00226	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—NPS—migraine	4.87e-05	0.00226	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—HTR2C—migraine	4.78e-05	0.00222	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HTR1B—migraine	4.66e-05	0.00217	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—EDNRA—migraine	4.65e-05	0.00216	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR1D—migraine	4.55e-05	0.00211	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HTR1A—migraine	4.49e-05	0.00208	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—CALCA—migraine	4.47e-05	0.00208	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—TAC1—migraine	4.42e-05	0.00205	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—NPS—migraine	4.42e-05	0.00205	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—TNF—migraine	4.4e-05	0.00204	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	4.4e-05	0.00204	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HTR2C—migraine	4.34e-05	0.00201	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR2B—migraine	4.23e-05	0.00196	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—EDNRA—migraine	4.22e-05	0.00196	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—HTR7—migraine	4.18e-05	0.00194	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CACNA1A—migraine	4.09e-05	0.0019	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CALCA—migraine	4.06e-05	0.00188	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HTR7—migraine	3.8e-05	0.00176	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—LRP1—migraine	3.72e-05	0.00173	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	3.69e-05	0.00171	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CACNA1A—migraine	3.59e-05	0.00167	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—TNF—migraine	3.58e-05	0.00166	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—ACE—migraine	3.45e-05	0.0016	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—HTR2A—migraine	2.93e-05	0.00136	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOTCH4—migraine	2.86e-05	0.00133	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—TNF—migraine	2.84e-05	0.00132	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	2.77e-05	0.00128	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR1B—migraine	2.76e-05	0.00128	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—TNF—migraine	2.72e-05	0.00126	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HTR2A—migraine	2.66e-05	0.00123	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR1A—migraine	2.65e-05	0.00123	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TAC1—migraine	2.61e-05	0.00121	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PGR—migraine	2.61e-05	0.00121	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NPS—migraine	2.61e-05	0.00121	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR2C—migraine	2.56e-05	0.00119	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EDNRA—migraine	2.49e-05	0.00116	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOTCH3—migraine	2.43e-05	0.00113	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CALCA—migraine	2.4e-05	0.00111	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR7—migraine	2.24e-05	0.00104	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CACNA1A—migraine	2e-05	0.000927	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TGFBR2—migraine	1.93e-05	0.000897	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CACNA1A—migraine	1.75e-05	0.000813	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CACNA1A—migraine	1.65e-05	0.000766	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR2A—migraine	1.57e-05	0.000729	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ESR1—migraine	1.39e-05	0.000647	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—MTHFR—migraine	1.35e-05	0.000628	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.34e-05	0.000622	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MTHFR—migraine	1.19e-05	0.000551	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CACNA1A—migraine	1.08e-05	0.000501	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MTHFR—migraine	6.61e-06	0.000307	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MTHFR—migraine	5.79e-06	0.000269	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MTHFR—migraine	5.46e-06	0.000253	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTHFR—migraine	3.57e-06	0.000166	CbGpPWpGaD
